BRCA2 and neoplasm: PEO1 was established when the tumor initially responded to PARP inhibitor treatment, and PEO4 cells are derived from the same patient when her tumor became PARPi resistant, which occurred when the original mutation in BRCA2 (Y1655* nonsense mutation) reverted to BRCA WT function [37].